Compound Detail
CHEMBL5201248
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5201248 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | DPNPYGJVEWBPON-JOCHJYFZSA-N |
1
Targets
2
Activities
2
Assay Types
13
PK Parameters
20
Publications
0
Known Names
Molecular Properties
379.5
MW (Da)
5.29
ALogP
4
HBA
2
HBD
77.4
PSA (Ų)
0.51
QED
1
Ro5 Violations
3
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 7.4
IC50 1 meas. best 7.85
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Leucine-rich repeat serine/threonine-protein kinase 2 CHEMBL1075104 | IC50 | 7.85 | 7.85 | 14.0 | 1 |
| Leucine-rich repeat serine/threonine-protein kinase 2 CHEMBL1075104 | EC50 | 7.4 | 7.4 | 40.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 60.72 | ng.hr.mL-1 | Mus musculus |
| AUC | 402.24 | ng.hr.mL-1 | Mus musculus |
| CL | 65.11 | ml/min | Mus musculus |
| Cmax | 310.0 | nM | Mus musculus |
| Cmax | 390.0 | nM | Mus musculus |
| F | 77.0 | % | Mus musculus |
| MRT | 0.51 | hr | Mus musculus |
| MRT | 2.7 | hr | Mus musculus |
| T1/2 | 0.2133 | hr | Mus musculus |
| T1/2 | 0.3667 | hr | Homo sapiens |
| T1/2 | 0.4 | hr | Mus musculus |
| T1/2 | 1.78 | hr | Mus musculus |
| Tmax | 50.0 | hr | Mus musculus |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Leucine-rich repeat serine/threonine-protein kinase 2 | IC50 | = | 14.0 | nM | 7.85 | Inhibition of full length wild type LRRK2 (unknown origin) by LRRKtide Adapta as... | 34992038 |
| Leucine-rich repeat serine/threonine-protein kinase 2 | EC50 | = | 40.0 | nM | 7.4 | Inhibition of pcDNA5FRT-TO-GFP fused - LRRK2 G2019S mutant (unknown origin) tran... | 34992038 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 34992038 | 10.1016/j.ejmech.2021.114080 | ADMET | 18 |
| 34992038 | 10.1016/j.ejmech.2021.114080 | Leucine-rich repeat serine/threonine-protein kinase 2 | 15 |
| 34992038 | 10.1016/j.ejmech.2021.114080 | Unchecked | 11 |
| 34992038 | 10.1016/j.ejmech.2021.114080 | ALK tyrosine kinase receptor | 3 |
| 34992038 | 10.1016/j.ejmech.2021.114080 | Dual specificity protein kinase CLK4 | 1 |
| 34992038 | 10.1016/j.ejmech.2021.114080 | Mitogen-activated protein kinase 8 | 1 |
| 34992038 | 10.1016/j.ejmech.2021.114080 | Serine/threonine-protein kinase TAO1 | 1 |
| 34992038 | 10.1016/j.ejmech.2021.114080 | Aurora kinase B | 1 |
| 34992038 | 10.1016/j.ejmech.2021.114080 | Receptor-type tyrosine-protein kinase FLT3 | 1 |
| 34992038 | 10.1016/j.ejmech.2021.114080 | Serine/threonine-protein kinase PLK4 | 1 |
| 34992038 | 10.1016/j.ejmech.2021.114080 | Serine/threonine-protein kinase D1 | 1 |
| 34992038 | 10.1016/j.ejmech.2021.114080 | High affinity nerve growth factor receptor | 1 |
| 34992038 | 10.1016/j.ejmech.2021.114080 | Serine/threonine-protein kinase 17A | 1 |
| 34992038 | 10.1016/j.ejmech.2021.114080 | Leukocyte tyrosine kinase receptor | 1 |
| 34992038 | 10.1016/j.ejmech.2021.114080 | Dual specificity protein kinase TTK | 1 |
| 34992038 | 10.1016/j.ejmech.2021.114080 | BDNF/NT-3 growth factors receptor | 1 |
| 34992038 | 10.1016/j.ejmech.2021.114080 | NT-3 growth factor receptor | 1 |
| 34992038 | 10.1016/j.ejmech.2021.114080 | NUAK family SNF1-like kinase 1 | 1 |
| 34992038 | 10.1016/j.ejmech.2021.114080 | Tyrosine-protein kinase JAK2 | 1 |
| 34992038 | 10.1016/j.ejmech.2021.114080 | AP2-associated protein kinase 1 | 1 |
Data from ChEMBL 36 via Core Engine